Csernok E - Search Results

1

Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin.

Richter C, Schnabel A, Csernok E, De Groot K, Reinhold-Keller E, Gross WL. Richter C, et al. Among authors: csernok e. Clin Exp Immunol. 1995 Jul;101(1):2-7. doi: 10.1111/j.1365-2249.1995.tb02268.x. Clin Exp Immunol. 1995. PMID: 7621588 Free PMC article.

2

Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity.

Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross WL. Schmitt WH, et al. Among authors: csernok e. Arthritis Rheum. 1992 Sep;35(9):1088-96. doi: 10.1002/art.1780350914. Arthritis Rheum. 1992. PMID: 1418025

3

Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues.

Braun MG, Csernok E, Gross WL, Müller-Hermelink HK. Braun MG, et al. Among authors: csernok e. Am J Pathol. 1991 Oct;139(4):831-8. Am J Pathol. 1991. PMID: 1656761 Free PMC article.

4

ANCA and infection.

Schmitt WH, Csernok E, Gross WL. Schmitt WH, et al. Among authors: csernok e. Lancet. 1991 Jun 8;337(8754):1416-7. doi: 10.1016/0140-6736(91)93102-f. Lancet. 1991. PMID: 1674791 No abstract available.

5

A human renal cancer line as a new antigen source for the detection of antibodies to cytoplasmic and nuclear antigens in sera of patients with Wegener's granulomatosis.

Mayet WJ, Hermann E, Csernok E, Knuth A, Poralla T, Gross WL, Meyer zum Büschenfelde KH. Mayet WJ, et al. Among authors: csernok e. J Immunol Methods. 1991 Sep 20;143(1):57-68. doi: 10.1016/0022-1759(91)90272-h. J Immunol Methods. 1991. PMID: 1717605

6

Antineutrophil cytoplasmic autoantibodies: immunobiological aspects.

Gross WL, Csernok E, Schmitt WH. Gross WL, et al. Among authors: csernok e. Klin Wochenschr. 1991 Sep 3;69(13):558-66. doi: 10.1007/BF01649318. Klin Wochenschr. 1991. PMID: 1721666 Review.

7

[Growth factors and cytokines in the pathogenesis of systemic vasculitis].

Gross WL, Csernok E, Kekow J. Gross WL, et al. Among authors: csernok e. Verh Dtsch Ges Inn Med. 1991;97:469-77. Verh Dtsch Ges Inn Med. 1991. PMID: 1808930 Review. German. No abstract available.

8

Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective.

Gross WL, Schmitt WH, Csernok E. Gross WL, et al. Among authors: csernok e. Am J Kidney Dis. 1991 Aug;18(2):175-9. doi: 10.1016/s0272-6386(12)80876-6. Am J Kidney Dis. 1991. PMID: 1867175

9

[Distribution pattern of proteinase 3 in Wegener's granulomatosis and other vasculitic diseases].

Braun MG, Csernok E, Müller-Hermelink HK, Gross WL. Braun MG, et al. Among authors: csernok e. Immun Infekt. 1991 Feb;19(1):23-4. Immun Infekt. 1991. PMID: 2060965 German. No abstract available.

10

Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: immunodiagnostic value, monoclonal antibodies and characterization of the target antigen.

Lüdemann J, Csernok E, Ulmer M, Lemke H, Utecht B, Rautmann A, Gross WL. Lüdemann J, et al. Among authors: csernok e. Neth J Med. 1990 Apr;36(3-4):157-62. Neth J Med. 1990. PMID: 2192294 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters